Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AmerisourceBergen

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance sells shares of AmerisourceBergen Corporation for $1.85 billion of initial proceeds.

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds

AbbVie

Johnson & Johnson

Healthcare stocks are generally thought of as safe or even recession-proof investments. This is because the underlying companies provide essential products and services that are required no matter what the broader economy is doing.

Sell Alert: 3 Healthcare Stocks to Dump ASAP

Walgreens Boots Alliance Inc ( WBA , Financial) recently experienced a 3.21% gain, with a share price of $30.52. Despite this, the company reported a Loss Per Share of $3.84.

Is Walgreens Boots Alliance Inc (WBA) a Value Trap? A Comprehensive Analysis

Alliance Resource Partners

AT&T

Dividend stocks have absolutely crushed non-payers in the return department when examined over long stretches. Since investment risk and yield tend to go hand-in-hand, stocks with high yields require some extra vetting.

3 Phenomenal Ultra-High-Yield Dividend Stocks Begging to Be Bought in August

This is the first RSV season in which older adults have the option to get vaccinated against the virus.

Walgreens is now offering RSV vaccines for older adults

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is offering flu and respiratory syncytial virus (RSV) vaccination appointments nationwide. Individuals ages 3 years and older can receive a flu shot, and eligible individuals ages 60 years and older can receive an RSV vaccine.* Patients can visit the pharmacy or schedule an appointment through the Walgreens app, by visiting Walgreens.com/ScheduleVaccine or by calling 1-800-WALGREENS. Walgreens makes it easy to help get ahead of respiratory virus seaso.

Walgreens Announces Vaccine and Testing Appointments in Preparation for Fall Respiratory Virus Season

Walgreens Boots Alliance is expanding into a diversified healthcare provider, aiming to become a significant competitor in the primary-care market. The company is shifting from a traditional retail pharmacy to a more diversified healthcare brand through acquisitions and reducing retail floor space. Despite challenges, WBA's healthcare segment is expected to have significant growth and contribute to the company's adjusted operating income in FY24.

Walgreens Boots Alliance Accelerates Healthcare Segment Despite Headwinds

Clorox

Ecolab

Essex Property Trust

Hormel Foods

Medtronic

Nordson

ProShares S&P 500 Dividend Aristocrats ETF

Realty Income Corp

SPDR S&P 500 ETF Trust

Stanley Black & Decker

Sysco

Target

T. Rowe Price Group

V.F.

The ProShares S&P 500 Dividend Aristocrat ETF had a strong month in June with a gain of 8.08%, year-to-date the Fund is up 5.72%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After nearly two full years of tracking these strategies, all 3 buy-and-hold portfolios continue to generate alpha over NOBL and SPY.

My Best Dividend Aristocrats For August 2023

Boeing

Cisco Systems

Chevron

Intel

Microsoft

Procter & Gamble

Travelers

Verizon

The Dow Jones recovered from yesterday's selloff to gain 0.5% as investors hoped that slowing inflation would end Fed rate hikes.

Dow Jones Today: Index Rebounds on Slowing Inflation

Shares of Walgreens Boots Alliance Inc. WBA, -2.58% fell 2.7% in afternoon trading Friday, enough to pace the Dow Jones Industrial Average's DJIA, +0.45% decliners, after the drugstore chain and health care services company said its chief financial officer was leaving after five years in the role. The selloff follows a 0.7% drop on Thursday that snapped a seven-day win streak, which was the longest in 11 months.

Walgreens stock leads the Dow's losers after ‘surprise' news of CFO departure

Amcor Plc

Franklin Resources

Federal Realty Investment Trust

For investors, 2022 was a dreadful year. The S&P 500 was down almost 20% and the Nasdaq lower by a stunning 33%.

The 7 Highest Yielding Dividend Aristocrats to Buy Right Now and Hold Forever

Agree Realty

CVS Health

Kohl's

NETLease Corporate Real Estate ETF

Net lease REITs have historically been solid performers. Elevated interest rates create some headwinds. So does an elevated likelihood of investment grade tenant credit migration.

Net Lease REITs In A New Era

Walgreens Boots Alliance said on Thursday Chief Financial Officer James Kehoe will step down in mid-August to pursue an opportunity in the technology sector.

Walgreens Boots Alliance CFO James Kehoe to step down

Walgreens said chief finance officer James Kehoe will leave the drugstore giant and the company will begin to search for a replacement with healthcare experience.

Walgreens CFO To Leave As Company Looks For Replacement With Healthcare Experience

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the departure of James Kehoe, Executive Vice President & Global Chief Financial Officer.

Walgreens Boots Alliance Announces CFO Transition

Advance Auto Parts

Walgreens, Verizon, and Advance Auto Parts all face daunting headwinds. Shares of the three companies are down over 14% so far this year.

3 Stocks That Haven't Been This Cheap in Over a Decade

Even the dividend aristocrats can fail, and history is clear when the dividend is cut, it's time to sell. Walgreens Boots Alliance, Inc.'s yield recently hit a record high as the market worries about the Pandemic bust crushing free cash flow and sending the payout ratio to almost 200%. Walgreens is facing significant business stress and at a 3% risk of cutting its dividend. But it will likely muddle along, with around 3% to 4% long-term growth.

Walgreens Is Cheap For A Reason: 2 Better 7+% Yielding Dividend Aristocrat Buys

On an annualized basis, dividend stocks have run circles around nonpayers over the long run. The 30-component Dow Jones Industrial Average is packed with more than two dozen time-tested dividend stocks.

Want $1,000 in Super-Safe Annual Dividend Income? Invest $13,750 Into the Following 2 Ultra-High-Yield Dow Stocks

Comcast

The stock market has been on fire, with the Standards and Practices  500 now just 5% away from its all-time high. Who would have thought that was in the cards for the first seven months of 2023?

Hidden Gems: 3 Stocks That Wall Street Is Missing Out On

Walgreens Boots Alliance continues to decline following a cut to earnings guidance. Verizon has fallen recently on concerns about liability for lead contamination.

Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?

Dow Inc

The Dogs of the Dow is a well-known investment strategy first published in 1991 by Michael Higgins.

The 5 Highest-Yielding Dogs of the Dow Could Be Huge Total Return Winners for Rest of 2023

Kellogg

PetMed Express

Kellogg is in the middle of a company revamp that should leave investors with a growth-focused business. Walgreens is working to integrate healthcare services into its pharmacy model.

3 Stocks to Buy Now That Are Yielding 3.5% to 8.8%

NORTHAMPTON, MA / ACCESSWIRE / July 18, 2023 / Walgreens Boots Alliance Originally published by Walgreens Boots Alliance June 5, 2023 marks the 50th anniversary of the first celebration of World Environment Day, an event led by the United Nations Environment Programme to bring businesses, governments and people together to act for a more sustainable planet. What began in 1972 as an environmental summit has grown to an international movement under the slogan "Only One Earth," and is the largest global platform for environmental outreach.

World Environment Day: Walgreens Boots Alliance's Progress in Review

Albertsons Companies

Phillips 66

Ryder System

Walgreens Boots Alliance today announced that its board of directors has declared a quarterly dividend of 48 cents per share, unchanged from the previous quarter. The dividend is payable on Sept. 12, 2023, to stockholders of record as of Aug. 21, 2023. Walgreens Boots Alliance and its predecessor company, Walgreen, have paid a dividend in 363 straight quarters or more than 90 years.

Daily Dividend Report: Walgreens Boots Alliance, CSX, Phillips 66, Ryder System, Albertsons

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens first-ever myW Days member event is coming July 23 through July 29 and myWalgreens members can earn unprecedented bonus offers, personalized deals and Walgreens Cash rewards across the entire store. As a thank you to its myWalgreens members for their loyalty, Walgreens will offer the highest Walgreens Cash rewards earnings opportunities to date. Members can begin clipping offers in their myWalgreens account on July 22. Walgreens Cash rewards earned du.

News for Walgreens Stock (WBA)